2019 annual financial data
Allogene Therapeutics 2019 Net income growth
Direct answer
Net income growth was 12.72%.
Operating income was -202,008,000 USD and net income was -184,594,000 USD.
Operating cash flow was -137,350,000 USD.
Get free Allogene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -202,008,000 USD
- Net income
- -184,594,000 USD
- Operating cash flow
- -137,350,000 USD